CN108159233A - 一种治疗糖尿病的中药组合物及其制备方法 - Google Patents
一种治疗糖尿病的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN108159233A CN108159233A CN201810163405.5A CN201810163405A CN108159233A CN 108159233 A CN108159233 A CN 108159233A CN 201810163405 A CN201810163405 A CN 201810163405A CN 108159233 A CN108159233 A CN 108159233A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- medicine composition
- chinese medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract 15
- 239000000203 mixture Substances 0.000 title claims abstract 15
- 238000002360 preparation method Methods 0.000 title claims abstract 12
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract 11
- 241000219780 Pueraria Species 0.000 claims abstract 7
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 claims abstract 6
- 240000000249 Morus alba Species 0.000 claims abstract 6
- 235000008708 Morus alba Nutrition 0.000 claims abstract 6
- 241000522254 Cassia Species 0.000 claims abstract 5
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract 5
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract 5
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract 5
- 244000235659 Rubus idaeus Species 0.000 claims abstract 5
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract 5
- 241000218989 Trichosanthes Species 0.000 claims abstract 5
- 239000009636 Huang Qi Substances 0.000 claims abstract 4
- 244000241838 Lycium barbarum Species 0.000 claims abstract 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 32
- 235000019441 ethanol Nutrition 0.000 claims 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 9
- 239000000243 solution Substances 0.000 claims 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims 7
- 238000000605 extraction Methods 0.000 claims 6
- 239000007788 liquid Substances 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 6
- 239000000706 filtrate Substances 0.000 claims 5
- 238000001914 filtration Methods 0.000 claims 5
- 239000002552 dosage form Substances 0.000 claims 4
- 238000010828 elution Methods 0.000 claims 4
- 239000008187 granular material Substances 0.000 claims 4
- 238000010438 heat treatment Methods 0.000 claims 4
- 244000046146 Pueraria lobata Species 0.000 claims 3
- 235000010575 Pueraria lobata Nutrition 0.000 claims 3
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 claims 3
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 claims 3
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 claims 3
- 239000003480 eluent Substances 0.000 claims 3
- 239000013558 reference substance Substances 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 2
- 239000012141 concentrate Substances 0.000 claims 2
- 238000001816 cooling Methods 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000002386 leaching Methods 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000011347 resin Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- 239000012085 test solution Substances 0.000 claims 2
- 238000001291 vacuum drying Methods 0.000 claims 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- 229920002101 Chitin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- 229920001353 Dextrin Polymers 0.000 claims 1
- 229920000896 Ethulose Polymers 0.000 claims 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000003957 anion exchange resin Substances 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 235000010410 calcium alginate Nutrition 0.000 claims 1
- 239000000648 calcium alginate Substances 0.000 claims 1
- 229960002681 calcium alginate Drugs 0.000 claims 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000003729 cation exchange resin Substances 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 238000000151 deposition Methods 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 229930003944 flavone Natural products 0.000 claims 1
- 150000002212 flavone derivatives Chemical class 0.000 claims 1
- 235000011949 flavones Nutrition 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000012535 impurity Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 235000010408 potassium alginate Nutrition 0.000 claims 1
- 239000000737 potassium alginate Substances 0.000 claims 1
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 239000013049 sediment Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 239000006228 supernatant Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229940098465 tincture Drugs 0.000 claims 1
- -1 tincture Substances 0.000 claims 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 239000008103 glucose Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗糖尿病的中药组合物及其制备方法,该中药组合物是由下述重量份的原料制成的:黄芪135~150份、桑叶115~130份、葛根总黄酮80~90份、天花粉70~90份、丹参60~80份、枸杞55~65重量份、甘草50~60份、山药40~50份、覆盆子30~45份、肉桂20~30份、泽泻20~30份、白芍15~20份。本发明的中药组合物可有效的控制血糖,使病人恢复健康,效果明显,治疗周期短且复发率低,不会产生对药物的依赖性,导致血糖难以控制。
Description
技术领域
本发明属于糖尿病药物领域,具体涉及一种治疗糖尿病的中药组合物及其制备方法。
背景技术
糖尿病是一种复合病因的综合病症,是由于体内胰岛素缺乏或拮抗胰岛素的激素增加,或胰岛素在靶细胞内不能发挥正常生理作用而引起的葡萄糖、蛋白质及脂质代谢紊乱的一种综合病症。其特征为血循环中葡萄糖浓度异常升高及尿糖、血糖过高时出现典型的“三多一少”症状,即多饮、多尿、多食及体重减轻,且伴有疲乏无力。严重者可发生酮症酸中毒、高渗性糖尿病昏迷,且易合并多种感染。随着病程的延长,其代谢紊乱可导致眼、肾、神经、血管及心脏等组织器官的慢性病变。若得不到及时、恰当的治疗,则发生心脏病变、脑血管病变、肾功能衰竭、双目失明、下肢坏死等情况,成为致残、致死的主要原因。且糖尿病发病率高,无论是发达国家或发展中国家,糖尿病的发病率都在逐年上升。
部分患者服用大量的降糖的药物,或者注射胰岛素来治疗糖尿病,结果出现病情的耐受性,只有服用大量剂量的降糖药才能有降血糖的效果,而使用胰岛素也会产生对药物的依赖性,导致血糖难以控制。致使这种情况发生的主要原因为是人们对糖尿病“及时治疗”的误解,中医对糖尿病的病因看法较正确,认为主要是过食肥甘、五志过极、房室不节、热病火燥及先天禀赋不足几个因素。其实对于糖尿病的治疗,患者在日常生活中应合理膳食,控制并养成良好的饮食习惯,然后通过适当的中药治疗,才能有效的控制血糖,稳定病情,恢复健康。
发明内容
本发明的目的是提供一种有效治疗糖尿病的中药组合物。
为达到上述目的,本发明中药组合物是由下述重量份的原料制成的:黄芪135~150份、桑叶115~130份、葛根总黄酮80~90份、天花粉70~90份、丹参60~80份、枸杞55~65重量份、甘草50~60份、山药40~50份、覆盆子30~45份、肉桂20~30份、泽泻20~30份、白芍15~20份。
本发明中,所述桑叶经过适当粉碎后,用乙醇加热提取,加热温度为67~73℃,乙醇用量为3~4倍桑叶重量,重复提取两次,然后滤去药渣,滤液在减压条件下浓缩后,通过醇沉法,使杂质沉淀,再经离心过滤,除去不溶物,清液上阳离子交换树脂,以蒸馏水洗尽不吸附的杂质,再用洗脱液洗脱,洗脱液浓缩后,上阴离子交换树脂,收集液浓缩,真空干燥,制成干粉。
本发明中,所述葛根总黄酮的制备方法包括以下步骤:
a)将药材葛根破碎,用70%乙醇液提取4~5次;
b)将步骤a所得的葛根提取液浓缩,浓缩液上大孔树脂,预吸附1~2小时,用5~8倍柱体积的水洗脱,再用4~7倍柱体积的40~60%乙醇洗脱,收集洗脱液,减压浓缩,真空干燥,得成品葛根总黄酮,以葛根提取物的总重量为基础计,葛根总黄酮的重量百分比为85%~99%。
优选的,本发明中药组合物是由下述重量份的原料制成的:黄芪143份、桑叶124份、葛根总黄酮85份、天花粉80份、丹参70份、枸杞60份、甘草55份、山药45份、覆盆子38份、肉桂25份、泽泻25份、白芍18份。
本发明的另一个目的提供该中药组合物的制备方法,该制备方法为:
(1)将山药、天花粉、覆盆子粉碎成细粉;
(2)白芍用65%的乙醇加热提取两次,每次1.5~2小时,合并浸提液,滤过,滤液浓缩至相对密度为1.2~1.3的稠膏;
(3)丹参用80%的乙醇加热提取两次,每次2~3小时,合并浸提液,滤过,滤液浓缩至相对密度为1.1~1.24的稠膏,
(4)将肉桂粉碎后,用70%~85%乙醇溶液提取两次,合并提取液,将提取液浓缩至无醇味,加两倍量的水稀释搅拌均匀,静置除去沉淀物,得到肉桂提取液;
(5)枸杞、黄芪、甘草、泽泻用水煎煮3~4次,每次2.5~3小时,合并煎煮液,过滤,滤液浓缩至相对密度为1.1~1.2的稠膏,冷却,加入乙醇使含醇量为50%~60%,静置,取上清液,回收乙醇,浓缩至相对密度1.2~1.3,与上述山药、天花粉、覆盆子的细粉、桑叶干粉、葛根总黄酮、(2)~(4)中所得稠膏和提取液合并,干燥,加药用辅料按常规制剂工艺制成临床所需剂型。
本发明中药组合物,可以通过常规的制剂工艺制备成为临床可接受的各种剂型如:颗粒剂、片剂、丸剂、胶囊剂、注射剂或口服液、酊剂、栓剂、合剂、散剂、洗剂、膜剂、滴丸等。
本发明中,中药组合物制得的制剂中还可以加入乙基羟乙基纤维素、甲壳素、甲基纤维素、海藻酸钠、海藻酸钾、海藻酸钙、羟乙基纤维素、羟丙基纤维素、糊精等。
优选的,本发明中药组合物的剂型为颗粒剂,该颗粒剂每克含黄芪甲苷0.3~0.5mg。
本发明中,所述黄芪甲苷的测定方法为:
色谱条件:十八烷基硅烷键合硅胶为填充剂;
流动相:比例为30∶63∶5的乙腈-水-四氢呋喃;
对照品溶液的制备:取黄芪甲苷对照品加甲醇制成每1ml含0.5mg的溶液,摇匀;
供试品溶液的制备:取本品颗粒剂,研匀,精密称取约10克,加水50ml溶解,滤过,滤液用乙醚脱脂3次,40ml水饱和的正丁醇振摇提取3次,合并正丁醇提取液,用30ml氨试液提取2次,弃去氨试液,用正丁醇饱和的水40ml洗,弃去水液,正丁醇液蒸干,残渣加水10mL使溶解,冷却,通过大孔吸附树脂柱,以100mL水洗脱,弃去水液,再用35%乙醇40ml洗脱,弃去35%乙醇洗脱液,继用60%乙醇80ml洗脱,收集洗脱液,蒸干,用甲醇溶解并转移至2ml量瓶内,加甲醇至刻度,摇匀,过滤,即得,分别精密吸取对照品溶液与供试品溶液各20μl,注入液相色谱仪测定。
本发明的中药组合物可有效的控制血糖,使病人恢复健康,效果明显,治疗周期短且复发率低,不会产生对药物的依赖性,导致血糖难以控制。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。此外,下面所描述的本发明各个实施方式中所涉及到的技术特征只要彼此之间未构成冲突就可以相互组合。
实施例1:
本实施例中药组合物是由下述重量份的原料制成的:黄芪143份、桑叶124份、葛根总黄酮85份、天花粉80份、丹参70份、枸杞60份、甘草55份、山药45份、覆盆子38份、肉桂25份、泽泻25份、白芍18份。
其中,桑叶经过适当粉碎后,用乙醇加热提取,加热温度为70℃,乙醇用量为3倍桑叶重量,重复提取两次,然后滤去药渣,滤液在减压条件下浓缩后,通过醇沉法,使杂质沉淀,再经离心过滤,除去不溶物,清液上阳离子交换树脂,以蒸馏水洗尽不吸附的杂质,再用洗脱液洗脱,洗脱液浓缩后,上阴离子交换树脂,收集液浓缩,真空干燥,制成干粉。
葛根总黄酮的制备方法为:
a)将药材葛根破碎,用70%乙醇液提取5次;
b)将步骤a所得的葛根提取液浓缩,浓缩液上大孔树脂,预吸附1.5小时,用6.5倍柱体积的水洗脱,弃去,再用6倍柱体积的50%乙醇洗脱,收集洗脱液,减压浓缩,真空干燥,得成品葛根总黄酮,以葛根提取物的总重量为基础计,葛根总黄酮的重量百分比为90%。
按下述制备方法制备本实施例的中药组合物:
(1)将山药、天花粉、覆盆子三味药粉碎成细粉;
(2)白芍用65%的乙醇加热提取两次,每次2小时,合并浸提液,滤过,滤液浓缩至相对密度为1.25的稠膏;
(3)丹参用80%的乙醇加热提取两次,每次2.5小时,合并浸提液,滤过,滤液浓缩至相对密度为1.15的稠膏,
(4)将肉桂粉碎后,用75%乙醇溶液提取两次,合并提取液,将提取液浓缩至无醇味,加两倍量的水稀释搅拌均匀,静置除去沉淀物,得到肉桂提取液;
(5)枸杞、黄芪、甘草、泽泻用水煎煮4次,每次2.5小时,合并煎煮液,过滤,滤液浓缩至相对密度为1.15的稠膏,冷却,加入乙醇使含醇量为55%,静置,取上清液,回收乙醇,浓缩至相对密度1.25,与上述山药、天花粉、覆盆子三味药的细粉、桑叶干粉、葛根总黄酮、(2)-(4)中所得稠膏和提取液合并,干燥,加药用辅料按常规制剂工艺制成颗粒剂,每克颗粒含黄芪甲苷0.35mg。
其中,黄芪甲苷的测定方法为:
色谱条件:十八烷基硅烷键合硅胶为填充剂;
流动相:比例为30∶63∶5的乙腈-水-四氢呋喃;
对照品溶液的制备:取黄芪甲苷对照品加甲醇制成每1ml含0.5mg的溶液,摇匀,即得;
供试品溶液的制备:取本发明颗粒剂,研匀,精密称取约10克,加水50ml溶解,滤过,滤液用乙醚脱脂3次,40ml水饱和的正丁醇振摇提取3次,合并正丁醇提取液,用30ml氨试液提取2次,弃去氨试液,用正丁醇饱和的水40ml洗,弃去水液,正丁醇液蒸干,残渣加水10mL使溶解,冷却,通过大孔吸附树脂柱,以100mL水洗脱,弃去水液,再用35%乙醇40ml洗脱,弃去35%乙醇洗脱液,继用60%乙醇80ml洗脱,收集洗脱液,蒸干,用甲醇溶解并转移至2ml量瓶内,加甲醇至刻度,摇匀,过滤,即得,分别精密吸取对照品溶液与供试品溶液各20μl,注入液相色谱仪测定。
实施例2:
年过花甲的李女士,患有糖尿病已经多年,血糖一直不平稳,而且伴有腰椎病的症状,为了解决这个问题,李女士吃过降糖药,打过胰岛素,但是血糖仍然降不下去,然而李女士合理膳食与作息,持续服用了本处方中药后,病情得到了不小的改变,李女士很是欣喜,每过一段时间血糖就会有平稳而有规律的下降,持续服用2个多月后,血糖稳定,已基本痊愈。
实施例3:
45的王先生,由于长期在商场的打拼,养成了很不好的饮食习惯与作息习惯,患有糖尿病,血糖时常不稳定,由于王先生考虑到糖尿病的慢性作用以及西药的副作用,未曾服用西药以及注射胰岛素,选择了本发明的中药,在服用本处方后半个月后,病情得到明显好转,持续服用2个多月后,血糖已经稳定,病情得到康复,现已基本痊愈。
实施例4:
本发明对造成大鼠肾上腺素高血糖模型的影响。
II型糖尿病是老年人的常见病、多发病。经临床疗效及实验证实,本发明中药组合物具有降血糖作用。本实验是用肾上腺素来加速大鼠体内糖元及脂肪分解,使大鼠血中葡萄糖浓度增高,肾上腺素还能抑制大鼠体内的胰岛素释放。同时再给大鼠灌一定剂量葡萄糖加速造成高血糖模型。
材料如下所示:
动物:Wistar大鼠,雌雄各半,体重为220±25g
药物:1.本发明原粉,药效剂量分别为临床用药量的20。
2.固本降糖胶囊。
方法与结果:
取大鼠24只,随机分为3组,每组8只。第一组为阴性对照组,给予蒸馏水。第二组为阳性对照组,给固本降糖胶囊,第三组给予本发明的中药,灌胃给药,药程一个月,末次给药后1小时,按500μg/kg的剂量注射肾上腺素,造成肾上腺高血糖模型,同时与葡萄糖1g/kg的剂量灌胃,加速模型地建立,采用葡萄糖氧化酶法分别测定空腹、半小时、1小时、2小时、3小时的血糖变化,其结果见表1。
表1本发明中药对肾上腺素造型大鼠血糖含量的影响
结果及讨论:
肾上腺素所致动物高血糖模型是用模拟应激性血糖增高的一种方法,相当于成人II型糖尿病患者的精神应激性刺激后的发病状态,因此具有一定的临床意义。而固本降糖胶囊能明显降低肾上腺素性高血糖已为过去的研究所证实,因此选用于本实验作为中药的阳性对照。本实验结果表明,本发明可以较好地抑制由肾上腺素所致的大鼠血糖增高反应,有明显的降血糖作用,可以用于治疗糖尿病。
本领域的技术人员容易理解,以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种治疗糖尿病的中药组合物,其特征在于,该中药组合物包括下述重量份数的组分:黄芪135~150份、桑叶115~130份、葛根总黄酮80~90份、天花粉70~90份、丹参60~80份、枸杞55~65重量份、甘草50~60份、山药40~50份、覆盆子30~45份、肉桂20~30份、泽泻20~30份、白芍15~20份。
2.根据权利要求1所述的治疗糖尿病的中药组合物,其特征在于,所述桑叶经过粉碎后,用乙醇加热提取,加热温度为67~73℃,乙醇用量为3~4倍桑叶重量,重复提取两次,然后滤去药渣,滤液在减压条件下浓缩后,通过醇沉法,使杂质沉淀,再经离心过滤,除去不溶物,清液上阳离子交换树脂,以蒸馏水洗尽不吸附的杂质,再用洗脱液洗脱,洗脱液浓缩后,上阴离子交换树脂,收集液浓缩,真空干燥,制成干粉。
3.根据权利要求1所述的治疗糖尿病的中药组合物,其特征在于,所述葛根总黄酮的制备方法包括以下步骤:
a)将药材葛根破碎,用70%乙醇液提取4~5次;
b)将步骤a所得的葛根提取液浓缩,浓缩液上大孔树脂,预吸附1~2小时,用5~8倍柱体积的水洗脱,再用4~7倍柱体积的40~60%乙醇洗脱,收集洗脱液,减压浓缩,真空干燥,得成品葛根总黄酮,以葛根提取物的总重量为基础计,葛根总黄酮的重量百分比为85%~99%。
4.根据权利要求1所述的治疗糖尿病的中药组合物,其特征在于,该中药组合物包括下述重量份数的组分:黄芪143份、桑叶124份、葛根总黄酮85份、天花粉80份、丹参70份、枸杞60份、甘草55份、山药45份、覆盆子38份、肉桂25份、泽泻25份、白芍18份。
5.根据权利要求1-4任一项所述的治疗糖尿病的中药组合物的制备方法,其特征在于,该制备方法包括以下步骤:
(1)将山药、天花粉、覆盆子粉碎成细粉;
(2)白芍用65%的乙醇加热提取两次,每次1.5~2小时,合并浸提液,滤过,滤液浓缩至相对密度为1.2~1.3的稠膏;
(3)丹参用80%的乙醇加热提取两次,每次2~3小时,合并浸提液,滤过,滤液浓缩至相对密度为1.1~1.24的稠膏;
(4)将肉桂粉碎后,用70%~85%乙醇溶液提取两次,合并提取液,将提取液浓缩至无醇味,加两倍量的水稀释搅拌均匀,静置除去沉淀物,得到肉桂提取液;
(5)枸杞、黄芪、甘草、泽泻用水煎煮3~4次,每次2.5~3小时,合并煎煮液,过滤,滤液浓缩至相对密度为1.1~1.2的稠膏,冷却,加入乙醇使含醇量为50%~60%,静置,取上清液,回收乙醇,浓缩至相对密度1.2~1.3,与上述山药、天花粉、覆盆子的细粉、桑叶干粉、葛根总黄酮、(2)-(4)中所得稠膏和提取液合并,干燥,加药用辅料按常规制剂工艺制成临床所需剂型。
6.根据权利要求5所述的治疗糖尿病的中药组合物的制备方法,其特征在于,所述剂型为颗粒剂、片剂、丸剂、胶囊剂、注射剂或口服液、酊剂、栓剂、合剂、散剂、洗剂、膜剂或滴丸。
7.根据权利要求5所述的治疗糖尿病的中药组合物的制备方法,其特征在于,所述剂型中还可以加入乙基羟乙基纤维素、甲壳素、甲基纤维素、海藻酸钠、海藻酸钾、海藻酸钙、羟乙基纤维素、羟丙基纤维素或糊精。
8.根据权利要求5所述的治疗糖尿病的中药组合物的制备方法,其特征在于,所述剂型为颗粒剂,该颗粒剂每克含黄芪甲苷0.3~0.5mg。
9.根据权利要求8所述所述的治疗糖尿病的中药组合物的制备方法,其特征在于,所述黄芪甲苷的测定方法为:
色谱条件:十八烷基硅烷键合硅胶为填充剂;
流动相:比例为30∶63∶5的乙腈-水-四氢呋喃;
对照品溶液的制备:取黄芪甲苷对照品加甲醇制成每1ml含0.5mg的溶液,摇匀;
供试品溶液的制备:取本品颗粒剂,研匀,精密称取约10克,加水50ml溶解,滤过,滤液用乙醚脱脂3次,40ml水饱和的正丁醇振摇提取3次,合并正丁醇提取液,用30ml氨试液提取2次,弃去氨试液,用正丁醇饱和的水40ml洗,弃去水液,正丁醇液蒸干,残渣加水10mL使溶解,冷却,通过大孔吸附树脂柱,以100mL水洗脱,弃去水液,再用35%乙醇40ml洗脱,弃去35%乙醇洗脱液,继用60%乙醇80ml洗脱,收集洗脱液,蒸干,用甲醇溶解并转移至2ml量瓶内,加甲醇至刻度,摇匀,过滤,即得,分别精密吸取对照品溶液与供试品溶液各20μl,注入液相色谱仪测定。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810163405.5A CN108159233A (zh) | 2018-02-27 | 2018-02-27 | 一种治疗糖尿病的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810163405.5A CN108159233A (zh) | 2018-02-27 | 2018-02-27 | 一种治疗糖尿病的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108159233A true CN108159233A (zh) | 2018-06-15 |
Family
ID=62511694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810163405.5A Pending CN108159233A (zh) | 2018-02-27 | 2018-02-27 | 一种治疗糖尿病的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108159233A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2161039C1 (ru) * | 2000-06-01 | 2000-12-27 | Научно-исследовательский центр традиционной фитотерапии | Способ лечения инсулинзависимого сахарного диабета и лекарственный сбор для лечения инсулинзависимого сахарного диабета |
CN1616014A (zh) * | 2004-09-17 | 2005-05-18 | 鲁南制药股份有限公司 | 一种治疗糖尿病的中药组合物及其制备方法 |
CN1726956A (zh) * | 2005-07-27 | 2006-02-01 | 南京海陵中药制药工艺技术研究有限公司 | 葛根总黄酮提取物及其制备方法和应用 |
-
2018
- 2018-02-27 CN CN201810163405.5A patent/CN108159233A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2161039C1 (ru) * | 2000-06-01 | 2000-12-27 | Научно-исследовательский центр традиционной фитотерапии | Способ лечения инсулинзависимого сахарного диабета и лекарственный сбор для лечения инсулинзависимого сахарного диабета |
CN1616014A (zh) * | 2004-09-17 | 2005-05-18 | 鲁南制药股份有限公司 | 一种治疗糖尿病的中药组合物及其制备方法 |
CN1726956A (zh) * | 2005-07-27 | 2006-02-01 | 南京海陵中药制药工艺技术研究有限公司 | 葛根总黄酮提取物及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
王文友: "《王文友行医60年临床经验集》", 31 July 2017, 中国中医药出版社 * |
王辉武: "《中医百家药论荟萃》", 28 February 2017, 重庆出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104840527A (zh) | 一种含远志糖酯和人参皂苷的组合物及用途 | |
CN103223016B (zh) | 一种防治糖尿病的人参桑菊组合物 | |
CN103071103B (zh) | 一种治疗流产的孕康口服液及其制备方法 | |
CN102224924A (zh) | 含有海参皂苷的组合物及其在食品药品中的应用 | |
CN101953887B (zh) | 用于防治糖尿病并发症的药物组合物及其制备方法 | |
CN103919939A (zh) | 芭蕉茎叶提取物在制备治疗或预防糖尿病的药物中的应用 | |
CN103432420B (zh) | 一种治疗糖尿病的中药组合物及其制备方法和检测方法 | |
CN107266599B (zh) | 金针菇多糖、提取方法及其在制备治疗功能性便秘药物方面的应用 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN108159233A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN105362454A (zh) | 一种具有辅助降糖功能的组合物及其制备方法和用途 | |
CN100528186C (zh) | 一种治疗慢性肾功能衰竭中药复方注射剂的制备工艺以及应用 | |
CN1076624A (zh) | 益津降糖制剂及其制备方法 | |
CN108159258A (zh) | 治疗伴有腰椎病的糖尿病中药组合物及其制备方法 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN106214787A (zh) | 一种治疗糖尿病的中药组合物及其制备方法与用途 | |
CN103191222B (zh) | 荷丹制剂在制备糖尿病药物中的应用 | |
CN106177416B (zh) | 一种降血糖的中药组合物及其制备方法 | |
CN102715502B (zh) | 一种具有抗糖尿病作用的保健食品的制备方法 | |
CN101559166A (zh) | 一种麦冬提取物及其制备方法与降糖应用 | |
CN107648397B (zh) | 一种用于治疗肝肾阴虚型的中药组合物及其制备方法和应用 | |
CN101204504A (zh) | 一种防治糖尿病的药物组合物及其制备方法 | |
CN104352748A (zh) | 一种治疗糖尿病肾病的中药组合物及其制备方法 | |
CN103989940A (zh) | 一种治疗糖尿病的中药组合物 | |
CN103285113A (zh) | 一种预防和/或治疗糖尿病的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |
|
RJ01 | Rejection of invention patent application after publication |